Long Covid Newsletter
Issue #8October 27, 20257 studies

Long COVID might be 4 different conditions - and your heart could be at risk for years

Long COVID might be 4 different conditions - and your heart could be at risk for years

Monday, Monday, October 27th Long Covid Newsletter Issue #8

New research is painting a clearer picture of what long COVID actually is - and it's more complex than we thought. Scientists are identifying distinct patterns, surprising surgical solutions, and concerning long-term heart risks that persist years after infection.

🧬 Long COVID Isn't One Thing - It's Four Distinct Conditions

Swedish researchers followed 470 people for 3 years and discovered that long COVID splits into four distinct patterns:

  • "Few Symptoms" (57% of patients) - mostly recovered with minimal issues

  • "Respiratory Symptoms" (14%) - primarily breathing problems and shortness of breath

  • "Neurocognitive Symptoms" (16%) - brain fog, memory issues, and concentration problems

  • "Multisystem Symptoms" (11%) - the worst group with problems affecting multiple body systems

Why this matters: Over half of patients improved over time, but those who were hospitalized during their initial COVID infection were much more likely to have persistent symptoms at 3 years. This classification system could help doctors predict who needs more intensive follow-up care and tailor treatments to specific symptom clusters.

Top 20% journal 🔗 Journal of Infection and Public Health 🗓️ Oct 14

Key Findings

💔 Your Heart Stays at Risk Years After COVID

A major study of 2,853 COVID patients found that even those who weren't hospitalized had a 48% higher risk of their heart function declining below normal levels. For hospitalized patients, the risk jumped to 81% higher for moderate decline and 179% higher for severe heart problems. The scary part? This elevated risk persisted throughout the entire follow-up period from 2016-2024.

💡 Even "mild" COVID can damage your heart long-term - and vaccination didn't seem to protect against this risk.
🥉 Top 5% journal 🔗 Journal of the American Heart Association 🗓️ Oct 14

🔧 Surgeons Are Fixing Long COVID Smell Loss

When medical treatments failed, doctors tried surgery on 4 patients who lost their sense of smell after COVID. They found scar tissue blocking the olfactory cleft (where smell happens) and surgically removed it, then inserted silicone plates to prevent re-scarring. All patients reported significant improvement within a week of removing the plates, with continued improvement over months.

💡 Sometimes long COVID symptoms have physical, fixable causes - not just mysterious neurological damage.

🏃‍♀️ Exercise Helps, But Long COVID Patients Stay Impaired

Researchers compared 94 long COVID patients to 100 recovered patients and 70 healthy controls during exercise testing. Long COVID patients could only reach 70% of predicted oxygen capacity (versus 81% and 85% in the other groups) and showed persistent breathing inefficiency. Even after 6 months, these problems didn't improve significantly.

💡 Long COVID creates lasting exercise limitations that don't just resolve with time - targeted rehabilitation is essential.
Top 50% journal 🔗 Respiratory Physiology and Neurobiology 🗓️ Oct 11

🧠 Losing Smell Predicts Brain Problems

A massive survey of 3,472 COVID patients across France and Mexico found that those with long-lasting smell loss were much more likely to report memory and attention problems. The longer someone's smell problems persisted, the more severe their cognitive difficulties became. Mood disorders were also significantly more common in patients who lost their sense of smell.

💡 Your nose and brain are more connected than you think - smell loss after COVID is a red flag for cognitive issues.
Top 30% journal 🔗 European Archives of Oto-Rhino-Laryngology 🗓️ Oct 18

🎯 MS Patients Have Lower Long COVID Risk

Surprisingly, only 6.5% of multiple sclerosis patients (7 out of 107) developed long COVID - much lower than the general population. However, those on older, less effective MS treatments were at much higher risk, with 71% of long COVID cases occurring in patients taking interferon, glatiramer acetate, or similar drugs. Having multiple COVID infections also increased risk significantly.

💡 Stronger immune-suppressing drugs might actually protect against long COVID - challenging assumptions about immunocompromised patients.
Top 20% journal 🔗 Multiple Sclerosis and Related Disorders 🗓️ Oct 18

🧘‍♀️ Adapted Exercise Programs Show Real Promise

50 long COVID patients completed a 6-week adapted physical activity program with two 30-minute cardiorespiratory sessions per week. The results were dramatic: patients with normal physical quality of life jumped from 16% at baseline to 90% immediately after the program, and remained at 66% during 5-7 month follow-up. Anxiety and depression scores also improved significantly.

💡 Structured, gentle exercise programs can dramatically improve long COVID symptoms - even when patients feel too sick to exercise.
Top 30% journal 🔗 Journal of Multidisciplinary Healthcare 🗓️ Oct 13

Implications

Long COVID is emerging as a collection of distinct conditions rather than a single syndrome, with some patients facing years-long heart risks and exercise limitations while others recover naturally. The good news: targeted interventions like adapted exercise programs and even surgery are showing real promise for helping the millions still struggling with persistent symptoms.

Studies in this issue

Primary sources used for this newsletter.

  1. Understanding Long-Term Symptoms After COVID-19: A Study of Four Key Patterns
    main storyJournal of infection and public health2025-10-14PMID 41086513
  2. Higher Risk of Long-Term Decrease in Heart Pumping Strength After COVID-19
    key findingJournal of the American Heart Association2025-10-14PMID 41085189
  3. Adapted Physical Activity May Improve Quality of Life and Mental Health in Long COVID Over Time
    key findingJournal of multidisciplinary healthcare2025-10-13PMID 41080807
  4. Impact of Smell Loss on Thinking and Feelings in COVID-19 Patients
    key findingEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025-10-18PMID 41109882
  5. Long COVID symptoms in multiple sclerosis linked to vaccine status, infection number, and treatments
    key findingMultiple sclerosis and related disorders2025-10-18PMID 41108810
  6. Breathing and energy limits in people with long COVID
    key findingRespiratory physiology & neurobiology2025-10-11PMID 41075953
  7. Sticky tissue in the nose linked to loss of smell after COVID-19
    key findingEuropean annals of otorhinolaryngology, head and neck diseases2025-10-14PMID 41087247

Continue reading

All Long Covid issues